Skip to content

Abivax

  • About Us
    • Company
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Science
    • Overview
    • Publications
  • Pipeline
    • Overview
    • ABX464 for UC
    • ABX464 for HIV
    • ABX196 for HCC
    • ABX544 for Ebola Virus
  • News & Events
    • Press Releases
    • Press Coverage
    • Upcoming Events
  • Investors
    • Overview
    • Share Price
    • Investor Documents
    • Annual General Meeting
    • UEG Week 2019
  • Contact Us
Search
  • EN
  • FR
  • DE

Investors

Annual General Meeting

The most recent Annual General Meeting has concluded, and took place on June 7, 2019 at Cabinet Dechert LLP in Paris. Please find documents regarding the AGM below:

(All documents in French)

  • Advance Notice of the Shareholders' Annual General Meeting
  • 2019 Registration Document
  • Notice of Convocation
  • Voting Form
  • Information regarding the total number of voting rights and shares as of May 3, 2019
  • Report of the Board of Directors to the Shareholders' Ordinary and Extraordinary General Meeting of June 7, 2019
  • Resolutions submitted to the Shareholders' Ordinary and Extraordinary General Meeting of June 7, 2019
  • Auditor's Report - Resolution n°11, 12, 15, 16, 17, 18, 19 and 20
  • Auditor's Report - Resolution n°10
  • Auditor's Report - Resolution n°14
  • Auditor's Report - Resolution n°21
  • Auditor's Report - Resolution n°22
  • Auditor's Report - Resolution n°23
  • Auditor's Report - Resolution n°25
  • Consolidated result for resolution vote (EGA)
  • Consolidated result for resolution vote (OGA)

Documents regarding the Annual General Meeting held on June 15, 2018 are available here.

Investor Contact

Chris Maggos LifeSci Advisors Chris@lifesciadvisors.com +41 79 367 6254
© 2019 All rights reserved by ABIVAX Privacy and Terms of Use
  • About Us
    • Company
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Science
    • Overview
    • Publications
  • Pipeline
    • ABX464 for UC
    • ABX464 for HIV
    • ABX196 for HCC
    • ABX544 for Ebola Virus
  • News & Events
    • Press Releases
    • Press Coverage
    • Upcoming Events
  • Investors
    • Share Profile
    • Share Price
    • Investor Documents
    • Analysts
    • Annual General Meeting
    • UEG Week 2019
Contact Us
  • Follow us on Twitter
  • Follow us on LinkedIn
  • Follow us on YouTube
  • Follow us on Google+